2026 Drug Cost Guide: Keytruda, Wegovy, Mounjaro, Zepbound, Opdivo & Imfinzi Prices

Updated U.S. drug cost data (Keytruda, Wegovy, Mounjaro, Zepbound) — Insurance, savings & 2026 trends.

Showing 31 - 36 of 38 drug pricing articles
Opdivo Cost per Month: Nivolumab Price & Insurance Coverage in the USA (2025) - 2026 Drug Cost Analysis

Opdivo Cost per Month: Nivolumab Price & Insurance Coverage in the USA (2025)

128 views

Opdivo (nivolumab) is one of the most widely used immunotherapy drugs in the United States, but its cost can be overwhelming for many cancer patients. In 2025, the monthly price of Opdivo ranges from $15,000 to over $20,000 before insurance, depending on dosage and treatment schedule. The good news is that Medicare, private insurance, and financial assistance programs can reduce these expenses significantly, sometimes lowering patient out-of-pocket costs to only a few hundred dollars per month. This guide explains the real cost of Opdivo per month, how insurance coverage works, and what assistance options are available to help patients manage treatment expenses.

Opdivo Cost in the USA: How Much Does Nivolumab Really Cost in 2025? - 2026 Drug Cost Analysis

Opdivo Cost in the USA: How Much Does Nivolumab Really Cost in 2025?

229 views

In 2025, the cost of Opdivo (Nivolumab) in the United States continues to be a major concern for cancer patients and families. With monthly expenses ranging from $12,000 to $26,000 without insurance, many wonder how they can afford this life-saving immunotherapy. This article explains the true price of Opdivo in 2025, how much insurance covers, available patient assistance programs, and how Opdivo compares to other cancer treatments like Keytruda and Yervoy. You’ll also find updated FAQs with trusted links to help patients make informed financial and medical decisions.

How Much Does Keytruda Cost Per Month? - 2026 Drug Cost Analysis

How Much Does Keytruda Cost Per Month?

389 views

Keytruda (pembrolizumab) has transformed cancer treatment, but its price tag remains one of the highest in oncology. In 2025, the average monthly cost of Keytruda in the United States is estimated at $15,000 to $16,000, depending on the dosing schedule. While list prices are staggering, most patients do not pay this full amount thanks to insurance coverage, Medicare benefits, and financial assistance programs. Still, questions like “How much does Keytruda cost per month?” and “Why is Keytruda so expensive?” are critical for patients, caregivers, and policymakers navigating the realities of modern cancer care.

Keytruda Price Per Infusion in USA | Updated 2025 Guide - 2026 Drug Cost Analysis

Keytruda Price Per Infusion in USA | Updated 2025 Guide

332 views

If you or a loved one is considering immunotherapy, understanding the real cost of treatment is crucial. In 2025, the price of Keytruda (pembrolizumab) per infusion in the USA remains a major factor for patients, caregivers, and healthcare providers. On average, a single infusion can cost between $9,800 and $11,500, depending on insurance coverage, treatment duration, and hospital charges. This updated guide explores the latest Keytruda prices, available financial assistance programs, and key insurance considerations to help you plan more effectively. You’ll also find official resources, FAQs, and expert insights, making this one of the most comprehensive guides to Keytruda treatment costs in the USA today.

How Much Does Opdivo Cost in the USA? | Nivolumab Price 2025 - 2026 Drug Cost Analysis

How Much Does Opdivo Cost in the USA? | Nivolumab Price 2025

343 views

In 2025, the cost of Opdivo (nivolumab) in the United States remains a major concern for cancer patients and caregivers. With list prices starting at around $7,600 per infusion and reaching over $36,000 per vial, understanding insurance coverage, financial assistance programs, and the newly approved subcutaneous form (Opdivo Qvantig) is essential. This guide explains the latest prices, cost-saving options, and answers the most common questions about Opdivo treatment in the U.S.

Keytruda Cost in the USA: How Much Does Pembrolizumab Really Cost in 2025? - 2026 Drug Cost Analysis

Keytruda Cost in the USA: How Much Does Pembrolizumab Really Cost in 2025?

907 views

Keytruda (pembrolizumab) is one of the most widely used immunotherapy drugs for treating different types of cancer, including lung cancer, melanoma, and head and neck cancers. In the United States, the cost of Keytruda can be a major concern for patients and their families, as it is often priced at several thousand dollars per infusion. This article explores the average cost of Keytruda in the USA, insurance coverage options, financial assistance programs, and helpful resources for patients seeking more affordable access.

Drug Price FAQs: Keytruda, Wegovy, Mounjaro & More

The average cost of Keytruda without insurance in 2026 is around $10,000 to $13,000 per dose. With insurance, out-of-pocket expenses can be as low as $100 depending on the coverage.

Experts expect Zepbound’s price to drop by 10–15% in 2026 as competition and insurance coverage expand. Savings cards and manufacturer programs are also expected to continue.

Wegovy costs between $25 and $150 per month with most insurance plans in the U.S. Without insurance, the price is around $1,350 monthly.

Top Drug Comparisons 2026: Keytruda, Mounjaro, Wegovy & Zepbound

Keytruda vs Opdivo

Compare the 2026 cost, effectiveness, and insurance coverage of both cancer treatments.

Compare Now

Wegovy vs Zepbound

Find out which weight-loss drug offers the best value and results in 2026.

Read Comparison

Mounjaro Savings 2026

Learn how to get the best savings and discounts for Mounjaro through insurance and cards.

See Savings